102 related articles for article (PubMed ID: 21198787)
1. Examination of AKAP12 promoter methylation in skin cancer using methylation-sensitive high-resolution melting analysis.
Wu W; Zhang J; Yang H; Shao Y; Yu B
Clin Exp Dermatol; 2011 Jun; 36(4):381-5. PubMed ID: 21198787
[TBL] [Abstract][Full Text] [Related]
2. Rapid determination of AKAP12 promoter methylation levels in peripheral blood using methylation-sensitive high resolution melting (MS-HRM) analysis: application in colorectal cancer.
Liu W; Guan M; Su B; Li J; Ma W; Liu C; Li M; Lin Y; Lu Y
Clin Chim Acta; 2010 Jul; 411(13-14):940-6. PubMed ID: 20227403
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of AKAP12 promoter methylation in human prostate cancer using methylation-sensitive high-resolution melting: correlation with Gleason score.
Liu W; Gong J; Hu J; Hu T; Sun Y; Du J; Sun C; Guan M; Jiang H; Lu Y
Urology; 2011 Apr; 77(4):1006.e1-7. PubMed ID: 21310466
[TBL] [Abstract][Full Text] [Related]
4. Quantitative assessment of AKAP12 promoter methylation in colorectal cancer using methylation-sensitive high resolution melting: Correlation with Duke's stage.
Liu W; Guan M; Su B; Ye C; Li J; Zhang X; Liu C; Li M; Lin Y; Lu Y
Cancer Biol Ther; 2010 Jun; 9(11):862-71. PubMed ID: 20364105
[TBL] [Abstract][Full Text] [Related]
5. Analysis of promoter hypermethylation of death-associated protein kinase and p16 tumor suppressor genes in actinic keratoses and squamous cell carcinomas of the skin.
Tyler LN; Ai L; Zuo C; Fan CY; Smoller BR
Mod Pathol; 2003 Jul; 16(7):660-4. PubMed ID: 12861061
[TBL] [Abstract][Full Text] [Related]
6. BRM and BRG1 subunits of the SWI/SNF chromatin remodelling complex are downregulated upon progression of benign skin lesions into invasive tumours.
Bock VL; Lyons JG; Huang XX; Jones AM; McDonald LA; Scolyer RA; Moloney FJ; Barnetson RS; Halliday GM
Br J Dermatol; 2011 Jun; 164(6):1221-7. PubMed ID: 21564052
[TBL] [Abstract][Full Text] [Related]
7. Methylation of AKAP12{alpha} promoter in lung cancer.
Jo UH; Whang YM; Sung JS; Kim YH
Anticancer Res; 2010 Nov; 30(11):4595-600. PubMed ID: 21115911
[TBL] [Abstract][Full Text] [Related]
8. E-cadherin promoter hypermethylation in preneoplastic and neoplastic skin lesions.
Chiles MC; Ai L; Zuo C; Fan CY; Smoller BR
Mod Pathol; 2003 Oct; 16(10):1014-8. PubMed ID: 14559984
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation.
Goeppert B; Schmidt CR; Geiselhart L; Dutruel C; Capper D; Renner M; Vogel MN; Zachskorn C; Zinke J; Campos B; Schmezer P; Popanda O; Wick W; Weller M; Meyermann R; Schittenhelm J; Harter PN; Simon P; Weichert W; Schirmacher P; Plass C; Mittelbronn M
J Neuropathol Exp Neurol; 2013 Oct; 72(10):933-41. PubMed ID: 24042196
[TBL] [Abstract][Full Text] [Related]
10. AKAP12, a gene with tumour suppressor properties, is a target of promoter DNA methylation in childhood myeloid malignancies.
Flotho C; Paulun A; Batz C; Niemeyer CM
Br J Haematol; 2007 Sep; 138(5):644-50. PubMed ID: 17686059
[TBL] [Abstract][Full Text] [Related]
11. Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation.
Wojdacz TK; Dobrovic A
Nucleic Acids Res; 2007; 35(6):e41. PubMed ID: 17289753
[TBL] [Abstract][Full Text] [Related]
12. AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity.
Choi MC; Jong HS; Kim TY; Song SH; Lee DS; Lee JW; Kim TY; Kim NK; Bang YJ
Oncogene; 2004 Sep; 23(42):7095-103. PubMed ID: 15258566
[TBL] [Abstract][Full Text] [Related]
13. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic silencing of AKAP12 in juvenile myelomonocytic leukemia.
Wilhelm T; Lipka DB; Witte T; Wierzbinska JA; Fluhr S; Helf M; Mücke O; Claus R; Konermann C; Nöllke P; Niemeyer CM; Flotho C; Plass C
Epigenetics; 2016; 11(2):110-9. PubMed ID: 26891149
[TBL] [Abstract][Full Text] [Related]
15. Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma.
Hibi K; Taguchi M; Nakayama H; Takase T; Kasai Y; Ito K; Akiyama S; Nakao A
Clin Cancer Res; 2001 Oct; 7(10):3135-8. PubMed ID: 11595706
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways.
Murao K; Kubo Y; Ohtani N; Hara E; Arase S
Br J Dermatol; 2006 Nov; 155(5):999-1005. PubMed ID: 17034532
[TBL] [Abstract][Full Text] [Related]
17. A-kinase anchoring protein 12 regulates the completion of cytokinesis.
Choi MC; Lee YU; Kim SH; Park JH; Kim HA; Oh DY; Im SA; Kim TY; Jong HS; Bang YJ
Biochem Biophys Res Commun; 2008 Aug; 373(1):85-9. PubMed ID: 18554502
[TBL] [Abstract][Full Text] [Related]
18. Aberrant DNA methylation in cutaneous malignancies.
van Doorn R; Gruis NA; Willemze R; van der Velden PA; Tensen CP
Semin Oncol; 2005 Oct; 32(5):479-87. PubMed ID: 16210089
[TBL] [Abstract][Full Text] [Related]
19. [Association between A-kinase anchor proteins 12 methylation and recurrence of hepatocellular carcinoma].
Liu ZJ; Liu W; Cui CH; Gu LK; Xing BC; Deng DJ
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Sep; 51(9):848-852. PubMed ID: 28881553
[No Abstract] [Full Text] [Related]
20. Aberrant promoter methylation in Chinese patients with non-small cell lung cancer: patterns in primary tumors and potential diagnostic application in bronchoalevolar lavage.
Chan EC; Lam SY; Tsang KW; Lam B; Ho JC; Fu KH; Lam WK; Kwong YL
Clin Cancer Res; 2002 Dec; 8(12):3741-6. PubMed ID: 12473584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
